Journal Article

Management of prosthetic valve thrombosis

D. Hering, C. Piper and D. Horstkotte

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 3, issue suppl_Q, pages Q22-Q26
Published in print December 2001 | ISSN: 1520-765X
Published online December 2001 | e-ISSN: 1554-2815 | DOI:
Management of prosthetic valve thrombosis

Show Summary Details


Fibrinolysis and surgery with either valvular re-replacement or thrombectomy are both established therapies for prosthetic valve thrombosis. In both treatment strategies, the complication rate depends to a similar degree on pre-interventional clinical and haemodynamic status. Fibrinolysis serves to avoid a second operation, but the incidence of recurrent thrombosis is higher. Before deciding in favour of thrombolytic therapy, structural defects of the prosthetic valve or tissue in-growth, which increase the risk of rethrombosis, should be ruled out by transoesophageal echocardiography. Apart from those cases in which there are contraindications to either treatment, we recommend surgery in cases of underlying prosthetic valve dysfunction or recurrent thrombosis.

Keywords: Prosthetic valve thrombosis; thrombectomy; thrombolytic therapy; valve replacement

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.